Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2024 Apr 1;5(3):100620. doi: 10.1016/j.xinn.2024.100620

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2024.

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

PMC Copyright notice

Organoid solves clinical difficulties in oncology: Pioneering models, therapies, and global trials

(A) Utilizing organoids for genetic replication in a groundbreaking manner. Organoids are an innovative method that successfully generates genetically homogeneous models for cancers, specifically those that demonstrate resistance to medicine or repeated spread to other parts of the body.

(B) Therapeutic innovations through organoid models. Utilizing the organoid-based genetic models, the scientific community is embarking on a journey of exploring and validating novel therapeutic regimens for tumors previously deemed untreatable.

(C) Organoids at the forefront of global clinical endeavors. The global initiation of clinical trials that harness the capabilities of organoids testifies to their transformative potential.